Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 11, 2007
Long-term outcome of simultaneous kissing stenting technique with sirolimus-eluting stent for large bifurcation coronary lesionsYoung-Hak Kim, Duk-Woo Park, Il-Woo Suh, et al.International Journal of Cardiology|January 15, 2008
Treatment of diffuse in-stent restenosis with drug-eluting stents vs. intracoronary beta-radiation therapy: INDEED StudySeong-Wook Park, Seung-Whan Lee, Bon Kwon Koo, et al.Thrombosis and Haemostasis|January 5, 2021
Pharmacodynamic Profile and Prevalence of Bleeding Episode in East Asian Patients with Acute Coronary Syndromes Treated with Prasugrel Standard-Dose versus De-escalation Strategy: A Randomized A-MATCH TrialYoung-Hoon Jeong, Ju-Hyeon Oh, Hyuck-Jun Yoon, et al.Clinical Cardiology|March 17, 2020
Additional postdilatation using noncompliant balloons after everolimus-eluting stent implantation: Results of the PRESS trialGyung-Min Park, Jae-Hwan Lee, Si Wan Choi, et al.Chinese Medical Journal|July 13, 2018
Efficacy of Pegylated Interferon Monotherapy versus Sequential Therapy of Entecavir and Pegylated Interferon in Hepatitis B e Antigen-Positive Hepatitis B Patients: A Randomized, Multicenter, Phase IIIb Open-Label Study (POTENT Study)Dae Won Jun, Sang Bong Ahn, Tae Yeob Kim, et al.The American Journal of Cardiology|March 23, 2011
Preventive strategies of renal insufficiency in patients with diabetes undergoing intervention or arteriography (the PREVENT Trial)Seung-Whan Lee, Won-Jang Kim, Young-Hak Kim, et al.European Heart Journal|August 31, 2025
Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous coronary intervention: the TAILORED-CHIP randomized clinical trialDo-Yoon Kang, Seong-Bong Wee, Jung-Min Ahn, et al.JACC. Cardiovascular Interventions|October 25, 2011
Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) TrialDuk-Woo Park, Young-Hak Kim, Hae-Geun Song, et al.Journal of the American College of Cardiology|March 12, 2011
A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trialSeung-Whan Lee, Seong-Wook Park, Young-Hak Kim, et al.The American Journal of Cardiology|September 26, 2013
Comparison of Zotarolimus-Eluting stent versus Sirolimus-Eluting stent for de novo coronary artery disease in patients with diabetes mellitus from the ESSENCE-DIABETES II trialGyung-Min Park, Seung-Whan Lee, Seong-Wook Park, et al.Pageof 4